← Leaderboards

Linda Mac Pherson Bradley

Trudeau Institute, Inc.

Google Scholar ↗PubMed ↗ORCID ↗

$20,175,528

Attributed

$21,373,634

Total exposure

27

Grants

23

Lead (contact PI)

Attributed= this PI's even-split share of every grant they're on (the fair, additive number). Exposure = full size of all those grants.

Funding over time

peak $1.7M · FY2005–25

$2M$1.5M$1M$500K$0

'05

'06

'07

'08

'09

'10

'11

'12

'13

'14

'15

'16

'17

'18

'19

'20

'21

'22

'23

'24

'25

Funding mix

By agency

NIH$21,373,634 · 27

By mechanism

R01$11,253,462 · 6

R21$3,918,087 · 8

P01$3,636,096 · 4

T32$957,477 · 1

R03$757,300 · 4

R56$458,250 · 1

Top collaborators

Scott N. Peterson4 shared

Others in their field

Top investigators on “Cells”

Lawrence Corey · Fred Hutchinson Cancer Center$536,344,731
Barton F Haynes · Duke University$457,457,619
David Heimbrook · Leidos Biomedical Research, Inc.$454,789,509
Glenda E Gray · Wits Health Consortium (Pty), Ltd$299,104,942
Dennis R. Burton · Scripps Research Institute$278,781,854
Mary M Horowitz · Medical College Of Wisconsin$237,383,608

Research focus

CellsResponseRegulationT-LymphocyteInsightT Cell ResponseCd4 Positive T LymphocytesCd8b1 GeneMalignant NeoplasmsInfectionVirus DiseasesMediatingCytokineSignal TransductionImmuneChronicCd8-Positive T-LymphocytesTumorPhenotypeReceptorImmune ResponseP-Selectin Ligand ProteinLigandsT Cell Regulation

Grant awards (72)

Rewiring T cell exhaustion with immune checkpoint blockade therapy$674,996

R01 · FY2025 · CA · contact PI

Immune Checkpoint Blockade Targeting the Novel PSGL-1/VISTA Axis for Pancreatic Cancer$268,345

R21 · FY2025 · CA · contact PI

Rewiring T cell exhaustion with immune checkpoint blockade therapy$674,996

R01 · FY2024 · CA · contact PI

Tumor Microenvironment and Cancer Immunology$47,964

P30 · FY2023 · CA · contact PI

Frontiers in Fundamental and Translational Immunology$149,305

T32 · FY2022 · AI · contact PI

Targeting Checkpoint Inhibition in Anti-Tumor Responses$97,500

R03 · FY2022 · CA · contact PI

Tumor Microenvironment and Cancer Immunology$47,964

P30 · FY2022 · CA · contact PI

Linking the microbiome and immune-checkpoint in melanoma by RNF5$603,580

R01 · FY2021 · CA · contact PI

Regulation of CD4+ T cell responses during chronic viral infection$243,750

R21 · FY2021 · AI · contact PI

Modulation of metabolism in TILs by the checkpoint inhibitor PSGL-1$227,906

R21 · FY2021 · CA · contact PI

Frontiers in Fundamental and Translational Immunology$189,317

T32 · FY2021 · AI · contact PI

Targeting Checkpoint Inhibition in Anti-Tumor Responses$97,500

R03 · FY2021 · CA · contact PI

Regulation of CD4+ T Cell Responses During Chronic Viral Infection$94,659

R21 · FY2021 · AI · contact PI

Tumor Microenvironment and Cancer Immunology$47,964

P30 · FY2021 · CA · contact PI

Linking the microbiome and immune-checkpoint in melanoma by RNF5$603,580

R01 · FY2020 · CA · contact PI

Regulation of CD4+ T cell responses during chronic viral infection$292,500

R21 · FY2020 · AI · contact PI

Modulation of metabolism in TILs by the checkpoint inhibitor PSGL-1$273,488

R21 · FY2020 · CA · contact PI

Frontiers in Fundamental and Translational Immunology$220,814

T32 · FY2020 · AI · contact PI

Tumor Microenvironment and Cancer Immunology$47,964

P30 · FY2020 · CA · contact PI

Linking the microbiome and immune-checkpoint in melanoma by RNF5$585,472

R01 · FY2019 · CA · contact PI

CD44 Promotes Chronic Virus Infection$243,750

R21 · FY2019 · AI · contact PI

Frontiers in Fundamental and Translational Immunology$204,749

T32 · FY2019 · AI · contact PI

Flow Cytometry$201,106

P30 · FY2019 · CA · contact PI

Linking the microbiome and immune-checkpoint in melanoma by RNF5$603,580

R01 · FY2018 · CA · contact PI

CD44 Promotes Chronic Virus Infection$292,500

R21 · FY2018 · AI · contact PI

Overcoming immune suppression in cancer by targeting PSGL-1 in T cells used for adoptive transfer$212,063

R21 · FY2018 · CA · contact PI

Frontiers in Fundamental and Translational Immunology$193,292

T32 · FY2018 · AI · contact PI

Linking the microbiome and immune-checkpoint in melanoma by RNF5$603,580

R01 · FY2017 · CA · contact PI

Regulation of Chronic Viral Infections$487,500

R01 · FY2017 · AI · contact PI

PSGL-1, a New Player in the Immune Checkpoint Landscape$254,475

R21 · FY2017 · CA · contact PI

Overcoming immune suppression in cancer by targeting PSGL-1 in T cells used for adoptive transfer$254,475

R21 · FY2017 · CA · contact PI

Reversal of T cell Exhaustion$97,500

R03 · FY2017 · AI · contact PI

Regulation of Chronic Viral Infections$487,500

R01 · FY2016 · AI · contact PI

PSGL-1, a New Player in the Immune Checkpoint Landscape$212,063

R21 · FY2016 · CA · contact PI

Reversal of T cell Exhaustion$97,500

R03 · FY2016 · AI · contact PI

Regulation of Chronic Viral Infections$487,500

R01 · FY2015 · AI · contact PI

Regulation of Chronic Viral Infections$487,500

R01 · FY2014 · AI · contact PI

Regulation of T cell homeostasis and memory$547,166

P01 · FY2013 · AI · contact PI

Regulation of Chronic Viral Infections$458,250

R56 · FY2013 · AI · contact PI

Regulation of T cell homeostasis and memory$595,834

P01 · FY2012 · AI · contact PI

Reporting IL-17 in Type 1 Diabetes$95,500

R03 · FY2012 · AI · contact PI

Regulation of T cell homeostasis and memory$603,778

P01 · FY2011 · AI · contact PI

Regulation of T cell homeostasis and memory$280,136

P01 · FY2011 · AI · contact PI

Control of T Cell Recruitment to Influenza Viruses in the Lung$236,363

R21 · FY2011 · AI · contact PI

Regulation of T cell homeostasis and memory$109,433

P01 · FY2011 · AI · contact PI

Reporting IL-17 in Type 1 Diabetes$95,500

R03 · FY2011 · AI · contact PI

Regulation of T cell homeostasis and memory$630,664

P01 · FY2010 · AI · contact PI

Control of T Cell Recruitment to Influenza Viruses in the Lung$286,500

R21 · FY2010 · AI · contact PI

CD4 T Cell Subsets in Type 1 Diabetes$238,750

R21 · FY2010 · AI · contact PI

Regulation of T cell homeostasis and memory$641,878

P01 · FY2009 · AI · contact PI

CD4 T Cell Subsets in Type 1 Diabetes$286,500

R21 · FY2009 · AI · contact PI

Regulation of T Cell Immunity to Influenza by CD44$321,988

R01 · FY2008 · AI · contact PI

Regulation of T Cell Immunity to Influenza by CD44$117,231

R01 · FY2008 · AI · contact PI

Regulation of T Cell Immunity to Influenza by CD44$448,695

R01 · FY2007 · AI · contact PI

Regulation of T Cell Immunity to Influenza by CD44$454,805

R01 · FY2006 · AI · contact PI

Regulation of T Cell Immunity to Influenza by CD44$465,750

R01 · FY2005 · AI

Control of Diabetes by Regulatory CD4 Cells$396,800

R01 · FY2005 · DK

Regulation of T Cell Immunity to Influenza by CD44$465,750

R01 · FY2004 · AI

Control of Diabetes by Regulatory CD4 Cells$396,800

R01 · FY2004 · DK

Control of Diabetes by Regulatory CD4 Cells$396,800

R01 · FY2003 · DK

Control of Diabetes by Regulatory CD4 Cells$396,800

R01 · FY2002 · DK

REGULATION OF HELPER T CELL MEMORY$253,190

R01 · FY2002 · AI

REGULATION OF T AND B CELL MIGRATION IN VIVO$0

P01 · FY2002 · AI

Control of Diabetes by Regulatory CD4 Cells$273,170

R01 · FY2001 · DK

REGULATION OF HELPER T CELL MEMORY$245,814

R01 · FY2001 · AI

Control of Diabetes by Regulatory CD4 Cells$81,430

R01 · FY2001 · DK

REGULATION OF DIABETES BY CHEMOKINES$49,228

R03 · FY2001 · AI

REGULATION OF DIABETES BY CHEMOKINES$38,922

R03 · FY2001 · AI

REGULATION OF T AND B CELL MIGRATION IN VIVO$0

P01 · FY2001 · AI

REGULATION OF HELPER T CELL MEMORY$238,655

R01 · FY2000 · AI

REGULATION OF T AND B CELL MIGRATION IN VIVO$227,207

P01 · FY2000 · AI

REGULATION OF DIABETES BY CHEMOKINES$88,150

R03 · FY2000 · AI